BioSpace News Archive

The Massachusetts Nurses Association is the largest union and professional association of registered nurses and health professionals in the Commonwealth

This marks the second time Pharmacy Times® has won.

Cipher Pharmaceuticals Inc. (TSX:CPH) (“Cipher” or “the Company”), in accordance with Toronto Stock Exchange requirements, announced today the voting results for the election of directors at its Annual and Special Meeting of Shareholders held on May 10, 2018 in Toronto, Ontario.

Seongnam-si (Seoul), South Korea – May 7, 2018 – Pharma Research Products Company Ltd. (PRP) a Korean publicly listed firm (KOSDAQ 214450) engaged in the development of medical esthetic products announced that it has secured majority ownership of botulinum toxin type A injection (ReNtox) production facility of BioCND, a South Korean venture company. The name of BioCND has been changed to Pharma Research BIO (PR Bio).

Soligenix’s revenues for the quarter ended March 31, 2018 were $1.1 million as compared to $1.3 million for the quarter ended March 31, 2017.

The International Academy of Oral Medicine and Toxicology is using this month to share information about fluoride’s potential to cause adverse health effects, especially in children.

Synergies between RXi’s self-delivering RNAi (sd-rxRNA®) therapeutic platform and Iovance’s TIL cell therapy approach will be explored preclinically

Four Gene Therapy Programs Potentially in Clinic in 2019 with Clinical Data from up to Two Programs

Company will close its Hayward, California-based facilities and operations.

ProMIS is a company focused on the discovery and development of precision treatments for neurodegenerative diseases